BMC research notes · 2026
Clinical value of contrast-enhanced ultrasound combined with intracavitary contrast-enhanced ultrasound in ultrasound-guided percutaneous transhepatic gallbladder drainage.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cai Huaijie, Wang Wei, Zeng Zhixiong
Аннотация
PURPOSE: To investigate the clinical value of contrast-enhanced ultrasound (CEUS) combined with intracavitary contrast-enhanced ultrasound (IC-CEUS) for percutaneous transhepatic gallbladder drainage (PTGD).
METHODS: Retrospective analysis was performed on the data of 42 patients who underwent PTGD in our hospital from January 2020 to January 2025. All patients underwent CEUS combined with IC-CEUS. The study included 20 males and 22 females, aged 35 to 98 years, with an average of 71.5 ± 9.7 years. This study did not establish a control group. Among them, 4 patients were required preoperative CEUS to evaluate due to adverse conditions and 38 patients were received postoperative CEUS combined with IC-CEUS due to postoperative abdominal pain and drainage obstruction.
RESULTS: The success rate of CEUS combined with IC-CEUS was 100%(42/42). All 4 patients with unsatisfactory ultrasound findings were effectively evaluated by preoperative CEUS. The causes of PTGD failure were identified in 73.7% (28/38) of the patients through postoperative CEUS combined with IC-CEUS. Among them, CEUS indicated 7.89%(3/38 95%CI:1.67%-21.37%) for perihepatic effusion and 5.26% (2/38 95%CI:0.64%-17.76%) for active hemorrhage of gallbladder. IC-CEUS indicated displacement of the drainage tube in 47.37% (18/38 95%CI:31.48%-63.69%) and blockage in 13.16% (5/38 95%CI:4.36%-28.25%) of the patients. 26.32% (10/38 95%CI:13.88%-42.31%) of the patients were not detected with any abnormalities during CEUS combined with IC-CEUS.
CONCLUSION: CEUS combined with IC-CEUS has potential value in evaluating PTGD and postoperative complications under specific circumstances. It may effectively guide clinical management.
METHODS: Retrospective analysis was performed on the data of 42 patients who underwent PTGD in our hospital from January 2020 to January 2025. All patients underwent CEUS combined with IC-CEUS. The study included 20 males and 22 females, aged 35 to 98 years, with an average of 71.5 ± 9.7 years. This study did not establish a control group. Among them, 4 patients were required preoperative CEUS to evaluate due to adverse conditions and 38 patients were received postoperative CEUS combined with IC-CEUS due to postoperative abdominal pain and drainage obstruction.
RESULTS: The success rate of CEUS combined with IC-CEUS was 100%(42/42). All 4 patients with unsatisfactory ultrasound findings were effectively evaluated by preoperative CEUS. The causes of PTGD failure were identified in 73.7% (28/38) of the patients through postoperative CEUS combined with IC-CEUS. Among them, CEUS indicated 7.89%(3/38 95%CI:1.67%-21.37%) for perihepatic effusion and 5.26% (2/38 95%CI:0.64%-17.76%) for active hemorrhage of gallbladder. IC-CEUS indicated displacement of the drainage tube in 47.37% (18/38 95%CI:31.48%-63.69%) and blockage in 13.16% (5/38 95%CI:4.36%-28.25%) of the patients. 26.32% (10/38 95%CI:13.88%-42.31%) of the patients were not detected with any abnormalities during CEUS combined with IC-CEUS.
CONCLUSION: CEUS combined with IC-CEUS has potential value in evaluating PTGD and postoperative complications under specific circumstances. It may effectively guide clinical management.